When you purchase our pharmacy software solutions, you become part of our community. As a team, we work together to guarantee you get the most out of your software while providing your pharmacy with the resources needed to be successful, ensuring your voice is heard, and continuously improving our services to aid you.
Effective December 4, 2018, the Minnesota Prescription Monitoring Program (MN PMP) moved controlled substance reporting to the Appriss® PMP Clearinghouse.
Of all the caregivers a patient encounters, community pharmacists are often the most accessible. There is increasing focus on how their availability and clinical know-how can be used to create better outcomes for patients, particularly the high-risk and chronically ill.
Once again, QS/1 is leading the way to help you make the transition from the current version of the National Council for Prescription Drug Programs (NCPDP) SCRIPT standard to the new one as smooth as possible. Pharmacies and prescribers that transmit electronic prescriptions have a little more than a year to convert to the new version. Currently, pharmacies and prescribers that wish to prescribe electronically must transmit those e-prescriptions using the SCRIPT Standard version 10.6. On January 1, 2020, transmissions must be made using the New SCRIPT Standard version 2017071.
QS/1 is honoring pharmacists at the 2018 National Community Pharmacists Association (NCPA) Annual Convention by donating to charities in the name of three pharmacists.
A new member of the J M Smith corporate family, Mevesi is now part of the Integra product suite. Already integrated with QS/1’s NRx and Integra’s PrimeCare, its platforms include Business Intelligence, Pharmacy Edge, and Transitions of Care geared to the pharmacy-hospital relationship.
Spartanburg, SC – August 29, 2018) QS/1 is pleased to be among the first pharmacy management system providers to participate in the Surescripts Early Adopter program for the new National Council for Prescription Drug Program’s (NCPDP) SCRIPT standard version 2017071. The Centers for Medicare and Medicaid Services (CMS) is working to implement the standard in early 2020.
Remember wondering: When will I ever use pharmacokinetic/pharmacodynamic (PK/PD) modeling? Recall constant musing over: How will I keep my patients loyal to me? Or, how can I have a new revenue stream that ties into my professional license? Well, enter personalized and precision pharmacotherapy.
The year 2017 and early 2018 have been quite a whirlwind for the pharmacy industry. In terms of market performance, dollar growth remains in the low, single digits, following the Hepatitis C bubble in 2014 and 2015.
Policymakers in Washington, DC, are exploring reforms to lower drug costs that could mark the most significant changes in decades to how the federal government pays for drugs.
The customer conference was exciting for Point-of-Sale (POS) customers as I reviewed updates, demoed the new SharpPOS, and showcased our new hardware. If you were unable to attend or would like a review, here are the highlights.
Addressing the medication needs of approximately 6,500 patients in more than 60 facilities across Georgia requires a blend of adept operations and commitment to customers. To do it successfully for 30 years in an ever-changing industry takes an open, flexible mindset.